


Searching News Database: adhesion barrier
HSMN NewsFeed - 29 Apr 2014
CryoLife Receives FDA 510(k) Clearance for PerClot(R) Topical Hemostatic Powder in the U.S.
CryoLife Receives FDA 510(k) Clearance for PerClot(R) Topical Hemostatic Powder in the U.S.
HSMN NewsFeed - 15 Nov 2011
Innocoll Enters Partnership with Merus Labs in Canada for the Distribution of CollaGUARD
Innocoll Enters Partnership with Merus Labs in Canada for the Distribution of CollaGUARD
HSMN NewsFeed - 11 Oct 2011
Innocoll Announces European Approval for CollaGUARD(R), Surgical Adhesion Barrier
Innocoll Announces European Approval for CollaGUARD(R), Surgical Adhesion Barrier
HSMN NewsFeed - 9 Mar 2009
FDA Approves SyntheMed's REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
FDA Approves SyntheMed's REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
HSMN NewsFeed - 2 Oct 2008
Covidien Introduces the SprayShield(TM) Adhesion Barrier System to the European Marketplace
Covidien Introduces the SprayShield(TM) Adhesion Barrier System to the European Marketplace
HSMN NewsFeed - 18 Jul 2008
SyntheMed Appoints Corinne Mundin as Director, International Market Development
SyntheMed Appoints Corinne Mundin as Director, International Market Development
HSMN NewsFeed - 20 Sep 2007
FDA Panel Recommends Approval of SyntheMed's REPEL-CV(R) Adhesion Barrier for Pediatric Patients
FDA Panel Recommends Approval of SyntheMed's REPEL-CV(R) Adhesion Barrier for Pediatric Patients
HSMN NewsFeed - 28 Mar 2007
FDA Accepts Synthemed's Pre-Market Approval (PMA) Application for REPEL-CV(R)
FDA Accepts Synthemed's Pre-Market Approval (PMA) Application for REPEL-CV(R)
HSMN NewsFeed - 16 Nov 2006
Comprehensive Review Published on FzioMed Technology for Postsurgical Adhesion Prevention
Comprehensive Review Published on FzioMed Technology for Postsurgical Adhesion Prevention
HSMN NewsFeed - 13 Oct 2006
Independent Studies on FzioMed's Anti-Adhesion Gel Presented at Spine Meetings
Independent Studies on FzioMed's Anti-Adhesion Gel Presented at Spine Meetings
HSMN NewsFeed - 6 Sep 2006
SyntheMed Announces Positive Pivotal Clinical Trial Results for REPEL-CV(R)
SyntheMed Announces Positive Pivotal Clinical Trial Results for REPEL-CV(R)
Additional items found! 27
Members Archive contains
27 additional stories matching:
adhesion barrier
(Password required)
adhesion barrier
(Password required)
